JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brenner, W.
Right arrow Articles by Eary, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brenner, W.
Right arrow Articles by Eary, J. F.
Journal of Nuclear Medicine Vol. 45 No. 9 1493-1500
© 2004 by Society of Nuclear Medicine


Clinical Investigations

Comparison of Different Quantitative Approaches to 18F-Fluoride PET Scans

Winfried Brenner, MD, PhD1, Cheryl Vernon, BS1, Mark Muzi, MS2, David A. Mankoff, MD, PhD1, Jeanne M. Link, PhD1, Ernest U. Conrad, MD3 and Janet F. Eary, MD1

1 Division of Nuclear Medicine, University of Washington Medical Center, Seattle, Washington
2 Department of Radiology, University of Washington Medical Center, Seattle, Washington
3 Department of Orthopedics, University of Washington Medical Center, Seattle, Washington

The aim of this study was to evaluate the relationship between 18F-fluoride bone metabolic measures obtained by nonlinear regression (NLR), Patlak analysis, and standardized uptake value (SUV) for a wide range of normal and pathologic bone conditions. In patients imaged twice, changes in metabolic rates were determined using the different quantitation methods. Methods: In 33 patients 2–51 mo after resection of a bone tumor of the limbs, a total of 42 dynamic PET scans were performed after injection of 250–350 MBq 18F-fluoride. SUV, fluoride bone influx rate obtained by Patlak analysis (KPat), and fluoride bone influx rate obtained by NLR (KNLR) were calculated in each patient for the bone graft, the contralateral normal side, and the spine, if within the field of view. Results: SUV ranged from 0.4 to 9.9, KPat from 0.0035 to 0.0742 mL/min/mL, and KNLR from 0.0027 to 0.0737 mL/min/mL. Significant linear correlations were found between KPat and KNLR (r = 0.99), KPat and SUV (r = 0.95), and KNLR and SUV (r = 0.93). Eight patients have been imaged twice within 6 mo. Changes in metabolic values of the grafts were significantly correlated for KPat and KNLR (r = 0.96), KPat and SUV (r = 0.88), and KNLR and SUV (r = 0.79). The 95% ranges of normal change in limb bones were ±58.0% for SUV, ±23.0% for KPat, and ±20.2% for KNLR; the corresponding 95% ranges in the spine were ±8.6%, ±7.6%, and ±19.6%. Conclusion: The results of this study show that 18F-fluoride metabolic values as well as changes in bone metabolism measured by SUV and Patlak analysis were strongly correlated with NLR findings. The high 95% range of normal change of SUV in limb bones, however, indicates that this parameter is of limited value in areas with low metabolic activity. The range of spontaneous bone metabolic rate fluctuations presented in this study may be used as an estimate for assessing changes in bone metabolic activity, and the normal values for limb bones provide a basis for further studies on 18F-fluoride bone metabolism.

Key Words: 18F-fluoride ion • PET • bone metabolism • nonlinear regression • Patlak graphical analysis • standardized uptake value


Related articles in JNM:

THIS MONTH IN JNM

JNM 2004 45: 8A-9A. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
K. Uchida, H. Nakajima, T. Miyazaki, T. Yayama, H. Kawahara, S. Kobayashi, T. Tsuchida, H. Okazawa, Y. Fujibayashi, and H. Baba
Effects of Alendronate on Bone Metabolism in Glucocorticoid-Induced Osteoporosis Measured by 18F-Fluoride PET: A Prospective Study
J. Nucl. Med., November 1, 2009; 50(11): 1808 - 1814.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. M. Blake, M. L. Frost, and I. Fogelman
Quantitative Radionuclide Studies of Bone
J. Nucl. Med., November 1, 2009; 50(11): 1747 - 1750.
[Full Text] [PDF]


Home page
Genes Dev.Home page
C. R. Walkley, R. Qudsi, V. G. Sankaran, J. A. Perry, M. Gostissa, S. I. Roth, S. J. Rodda, E. Snay, P. Dunning, F. H. Fahey, et al.
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
Genes & Dev., June 15, 2008; 22(12): 1662 - 1676.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. L. Frost, G. M. Blake, S.-J. Park-Holohan, G. J.R. Cook, K. M. Curran, P. K. Marsden, and I. Fogelman
Long-Term Precision of 18F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism
J. Nucl. Med., May 1, 2008; 49(5): 700 - 707.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Installe, A. Nzeusseu, A. Bol, G. Depresseux, J.-P. Devogelaer, and M. Lonneux
18F-Fluoride PET for Monitoring Therapeutic Response in Paget's Disease of Bone
J. Nucl. Med., October 1, 2005; 46(10): 1650 - 1658.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.